Climate-related reporting in financial statements
Pharmaceuticals, as one of the largest global industries, has a significant role to play when it comes to climate change.
Corporate reporting for pharma and life sciences
IndustriesHealthcare & Life SciencePharma & life sciencesPharma & life sciences insights
Corporate reporting for pharma and life sciences
A roundup of the latest trends and developments in corporate reporting for the life sciences and pharmaceutical industry.
Good corporate reporting provides a window into your organisation. It’s an opportunity to tell your story, providing confidence for investors and building trust with stakeholders.
Pharma R&D trends and accounting implications
Research and development is at the heart of the pharmaceutical industry and, more generally, the wider life sciences sector. The significance of R&D to the life sciences sector is clearly evidenced by the cumulative R&D expenditure.
Reporting financial and non-financial measures
Companies operating in the pharmaceutical sector report on many different metrics and KPIs, including GAAP measures under IFRS, other financial Alternative Performance Measures (APMs) and other non-financial measures often linked to strategic objectives.
Spotlight on provisions and contingencies
Provisions and contingent liabilities are an accounting area which has recently been getting an increasing amount of attention.
Contacts
Steve Brice Partner – Head of Accounting Technical Services
Related page
Pharma & life sciences insights
Explore all our expert analysis and insights for the pharma and life sciences sector.